varenicline ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
nicotinic acetylcholine receptor partial agonists/agonists 2808 249296-44-4

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • varenicline
  • champix
  • chantix
  • varenicline tartrate
  • CP-526,555-18
A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.
  • Molecular weight: 211.27
  • Formula: C13H13N3
  • CLOGP: 0.90
  • LIPINSKI: 0
  • HAC: 3
  • HDO: 1
  • TPSA: 37.81
  • ALOGS: -3.38
  • ROTB: 0

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
2 mg O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 3 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 0.20 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 92 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 0.14 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability) 87 % Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H

Approvals:

DateAgencyCompanyOrphan
May 10, 2006 FDA PFIZER INC

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Abnormal dreams 2635.47 17.35 714 35328 8663 50560419
Depression 1265.19 17.35 999 35043 164424 50404658
Suicidal ideation 1241.41 17.35 659 35383 54726 50514356
Nausea 1030.02 17.35 1805 34237 703593 49865489
Nightmare 822.29 17.35 339 35703 15747 50553335
Anger 582.97 17.35 240 35802 11093 50557989
Feeling abnormal 567.51 17.35 564 35478 124928 50444154
Anxiety 564.16 17.35 662 35380 176944 50392138
Insomnia 514.49 17.35 627 35415 174238 50394844
Crying 409.21 17.35 226 35816 20190 50548892
Tobacco user 408.11 17.35 97 35945 654 50568428
Irritability 404.41 17.35 252 35790 28174 50540908
Aggression 375.16 17.35 216 35826 20900 50548182
Agitation 371.17 17.35 306 35736 53078 50516004
Mood swings 282.82 17.35 163 35879 15791 50553291
Mood altered 276.97 17.35 149 35893 12624 50556458
Depressed mood 272.53 17.35 212 35830 33811 50535271
Abnormal behaviour 261.30 17.35 167 35875 19491 50549591
Dysgeusia 223.39 17.35 200 35842 38716 50530366
Nervousness 216.44 17.35 170 35872 27481 50541601
Flatulence 213.28 17.35 173 35869 29285 50539797
Paranoia 192.15 17.35 109 35933 10239 50558843
Thinking abnormal 189.12 17.35 105 35937 9462 50559620
Panic attack 175.76 17.35 130 35912 19212 50549870
Homicidal ideation 175.38 17.35 60 35982 1642 50567440
Emotional disorder 168.39 17.35 105 35937 11731 50557351
Tearfulness 155.96 17.35 68 35974 3619 50565463
Off label use 152.49 17.35 74 35968 474352 50094730
Disturbance in attention 143.85 17.35 142 35900 31044 50538038
Sleep disorder 143.40 17.35 190 35852 57093 50511989
Mental disorder 142.20 17.35 121 35921 21870 50547212
Psychotic disorder 130.88 17.35 115 35927 21697 50547385
Mania 128.56 17.35 86 35956 10830 50558252
Drug hypersensitivity 127.05 17.35 430 35612 250580 50318502
Acute kidney injury 105.12 17.35 18 36024 228040 50341042
Suicidal behaviour 101.83 17.35 44 35998 2290 50566792
Death 99.52 17.35 54 35988 325325 50243757
Anaemia 98.21 17.35 29 36013 252427 50316655
Vomiting 95.57 17.35 607 35435 460151 50108931
Personality change 95.56 17.35 56 35986 5589 50563493
Amnesia 93.38 17.35 132 35910 42128 50526954
Rheumatoid arthritis 89.02 17.35 18 36024 202532 50366550
Tobacco withdrawal symptoms 88.68 17.35 15 36027 6 50569076
Suicide attempt 86.57 17.35 142 35900 51590 50517492
Weight increased 85.10 17.35 326 35716 201565 50367517
Bipolar disorder 83.83 17.35 55 35987 6702 50562380
Infusion related reaction 83.57 17.35 11 36031 169546 50399536
Pyrexia 83.22 17.35 89 35953 380114 50188968
Neutropenia 82.33 17.35 6 36036 147959 50421123
Dizziness 82.31 17.35 473 35569 345896 50223186
Hallucination 82.06 17.35 131 35911 46526 50522556
Self-injurious ideation 81.11 17.35 37 36005 2192 50566890
Malaise 76.33 17.35 453 35589 335079 50234003
Stress 74.74 17.35 136 35906 53657 50515425
Hostility 72.56 17.35 32 36010 1750 50567332
Systemic lupus erythematosus 69.58 17.35 9 36033 140613 50428469
Toxicity to various agents 66.77 17.35 34 36008 212465 50356617
Alopecia 66.09 17.35 47 35995 245000 50324082
Violence-related symptom 65.42 17.35 20 36022 378 50568704
Fear 64.76 17.35 65 35977 14484 50554598
General physical health deterioration 61.84 17.35 13 36029 142421 50426661
Thrombocytopenia 61.21 17.35 9 36033 127664 50441418
Chronic obstructive pulmonary disease 59.45 17.35 123 35919 53312 50515770
Impaired work ability 58.99 17.35 60 35982 13580 50555502
Impaired driving ability 58.51 17.35 36 36006 3925 50565157
Headache 56.83 17.35 580 35462 505955 50063127
Panic reaction 56.73 17.35 34 36008 3535 50565547
Arthropathy 56.34 17.35 21 36021 157885 50411197
Apathy 56.01 17.35 45 35997 7503 50561579
Memory impairment 56.01 17.35 153 35889 79207 50489875
Feeling jittery 55.54 17.35 53 35989 11107 50557975
Euphoric mood 55.22 17.35 35 36007 4020 50565062
Hypersomnia 54.95 17.35 61 35981 15253 50553829
Joint swelling 54.05 17.35 57 35985 245229 50323853
Infection 53.83 17.35 28 36014 172926 50396156
Palpitations 52.20 17.35 167 35875 94339 50474743
Nicotine dependence 51.90 17.35 19 36023 636 50568446
Somnambulism 51.36 17.35 36 36006 4888 50564194
Sepsis 50.31 17.35 16 36026 132909 50436173
Decreased interest 49.00 17.35 29 36013 2947 50566135
Hallucination, auditory 47.87 17.35 48 35994 10680 50558402
Peripheral swelling 47.47 17.35 46 35996 205890 50363192
Exposure during pregnancy 45.03 17.35 15 36027 121000 50448082
Dissociation 44.87 17.35 25 36017 2266 50566816
Urinary tract infection 43.00 17.35 58 35984 223962 50345120
Parosmia 42.96 17.35 31 36011 4405 50564677
Product use issue 42.51 17.35 27 36015 149448 50419634
Psychiatric symptom 42.14 17.35 31 36011 4539 50564543
Withdrawal syndrome 41.92 17.35 57 35985 17533 50551549
Constipation 41.62 17.35 250 35792 185458 50383624
Tremor 41.51 17.35 177 35865 114726 50454356
White blood cell count decreased 40.83 17.35 16 36026 116706 50452376
Therapeutic product effect incomplete 40.44 17.35 8 36034 91507 50477575
Social avoidant behaviour 40.24 17.35 25 36017 2772 50566310
Therapeutic response unexpected 40.11 17.35 53 35989 15862 50553220
Poor quality sleep 39.75 17.35 54 35988 16592 50552490
Hypotension 39.37 17.35 67 35975 235402 50333680
Screaming 38.80 17.35 25 36017 2953 50566129
Sinusitis 38.26 17.35 39 36003 170519 50398563
Cardiac failure 37.28 17.35 5 36037 76035 50493047
Disease progression 37.24 17.35 11 36031 95855 50473227
Product use in unapproved indication 37.15 17.35 18 36024 115801 50453281
Hyperphagia 36.38 17.35 19 36023 1513 50567569
Pleural effusion 36.25 17.35 7 36035 81447 50487635
Hypokalaemia 36.24 17.35 9 36033 87983 50481099
Somnolence 36.23 17.35 211 35831 154774 50414308
Hepatic enzyme increased 36.15 17.35 27 36015 137353 50431729
Pneumonia 36.10 17.35 143 35899 378258 50190824
Arthralgia 35.69 17.35 176 35866 438526 50130556
Haemoglobin decreased 34.78 17.35 24 36018 127192 50441890
Renal impairment 34.75 17.35 6 36036 75655 50493427
Impatience 34.61 17.35 12 36030 342 50568740
Impulsive behaviour 34.39 17.35 18 36024 1440 50567642
Pre-existing condition improved 33.98 17.35 33 36009 7064 50562018
Blood creatinine increased 32.94 17.35 7 36035 76153 50492929
Respiratory failure 32.72 17.35 12 36030 91169 50477913
Glossodynia 32.68 17.35 21 36021 115548 50453534
Affect lability 32.55 17.35 36 36006 8962 50560120
Energy increased 32.07 17.35 20 36022 2232 50566850
Hospitalisation 32.06 17.35 5 36037 67932 50501150
Leukopenia 31.80 17.35 5 36037 67523 50501559
Feelings of worthlessness 31.67 17.35 11 36031 315 50568767
Wound 31.62 17.35 18 36024 105776 50463306
Impaired healing 31.04 17.35 6 36036 69780 50499302
Drug withdrawal syndrome 30.58 17.35 60 35982 25021 50544061
Psychomotor hyperactivity 29.90 17.35 35 36007 9266 50559816
Nasopharyngitis 29.47 17.35 58 35984 192869 50376213
Renal failure 29.30 17.35 20 36022 106613 50462469
Platelet count decreased 28.89 17.35 18 36024 100708 50468374
Lower respiratory tract infection 28.74 17.35 16 36026 95185 50473897
Swelling 28.48 17.35 63 35979 200809 50368273
Affective disorder 28.46 17.35 26 36016 5155 50563927
Tachyphrenia 28.31 17.35 15 36027 1230 50567852
Bipolar I disorder 28.20 17.35 16 36026 1502 50567580
Abdominal pain upper 28.08 17.35 202 35840 159107 50409975
Abdominal distension 27.63 17.35 114 35928 72789 50496293
Negative thoughts 27.25 17.35 13 36029 853 50568229
Incorrect dose administered 27.12 17.35 86 35956 48328 50520754
Oedema mouth 26.86 17.35 18 36024 2272 50566810
Vision blurred 26.74 17.35 119 35923 78528 50490554
Physical assault 26.66 17.35 13 36029 895 50568187
Alcohol use 26.62 17.35 17 36025 1978 50567104
Middle insomnia 26.49 17.35 34 36008 9887 50559195
Feeling guilty 26.47 17.35 11 36031 519 50568563
Feeling of despair 26.44 17.35 17 36025 2001 50567081
Delusion 26.33 17.35 35 36007 10534 50558548
Gastrointestinal haemorrhage 25.72 17.35 10 36032 73311 50495771
Formication 25.50 17.35 21 36021 3625 50565457
Depression suicidal 25.43 17.35 15 36027 1514 50567568
Cardio-respiratory arrest 25.35 17.35 4 36038 53888 50515194
Therapeutic product effect decreased 25.30 17.35 36 36006 136014 50433068
Ageusia 25.30 17.35 36 36006 11547 50557535
Interstitial lung disease 24.90 17.35 4 36038 53172 50515910
Restlessness 24.60 17.35 55 35987 25118 50543964
Increased appetite 24.47 17.35 30 36012 8331 50560751
Hot flush 24.32 17.35 78 35964 44091 50524991
Weaning failure 24.26 17.35 9 36033 313 50568769
Condition aggravated 24.21 17.35 119 35923 296939 50272143
Pain 24.20 17.35 280 35762 578623 49990459
Flight of ideas 23.73 17.35 9 36033 333 50568749
Frustration tolerance decreased 22.80 17.35 24 36018 5650 50563432
Atrial fibrillation 21.98 17.35 24 36018 101721 50467361
Musculoskeletal stiffness 21.97 17.35 36 36006 128445 50440637
Tobacco abuse 21.96 17.35 10 36032 590 50568492
Chest pain 21.87 17.35 207 35835 176675 50392407
Restless legs syndrome 21.82 17.35 40 36002 15857 50553225
Septic shock 21.41 17.35 7 36035 57168 50511914
Recalled product administered 21.11 17.35 9 36033 453 50568629
Multiple organ dysfunction syndrome 21.02 17.35 5 36037 50332 50518750
COVID-19 20.78 17.35 4 36038 46658 50522424
Injection site erythema 20.66 17.35 14 36028 74922 50494160
Drug ineffective 20.47 17.35 437 35605 818896 49750186
C-reactive protein increased 20.31 17.35 11 36031 66463 50502619
Drug interaction 20.10 17.35 224 35818 199397 50369685
Mental impairment 20.05 17.35 33 36009 12011 50557071
Injection site pain 20.03 17.35 30 36012 110994 50458088
Loss of employment 19.89 17.35 13 36029 1573 50567509
Completed suicide 19.83 17.35 40 36002 131849 50437233
Cellulitis 19.82 17.35 13 36029 70785 50498297
Laziness 19.81 17.35 9 36033 528 50568554
Morbid thoughts 19.73 17.35 9 36033 533 50568549
Hyperkalaemia 19.64 17.35 5 36037 48084 50520998
Flat affect 19.63 17.35 12 36030 1293 50567789
Depressive symptom 19.44 17.35 17 36025 3183 50565899
Hyponatraemia 19.34 17.35 24 36018 96115 50472967
Psychotic behaviour 19.25 17.35 9 36033 564 50568518
Hyperhidrosis 19.12 17.35 119 35923 89307 50479775
Cardiac arrest 18.89 17.35 19 36023 83632 50485450
Drug intolerance 18.88 17.35 86 35956 219018 50350064
Gingival bleeding 18.75 17.35 31 36011 11322 50557760
Osteoarthritis 18.67 17.35 13 36029 68593 50500489
Neuropathy peripheral 18.59 17.35 25 36017 96732 50472350
Alcohol interaction 18.55 17.35 14 36028 2130 50566952
Oxygen saturation decreased 18.49 17.35 15 36027 73233 50495849
Dehydration 18.34 17.35 52 35990 152397 50416685
Drug abuse 18.14 17.35 10 36032 59836 50509246
Disorientation 18.04 17.35 61 35981 35423 50533659
Emphysema 18.03 17.35 27 36015 9066 50560016
Metabolic acidosis 18.00 17.35 3 36039 38822 50530260
Nocturia 17.87 17.35 23 36019 6707 50562375
Therapy non-responder 17.82 17.35 7 36035 51015 50518067
Major depression 17.46 17.35 23 36019 6861 50562221

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Abnormal dreams 1928.37 18.41 528 21471 6392 29546136
Depression 1274.02 18.41 788 21211 84359 29468169
Suicidal ideation 1207.72 18.41 564 21435 34152 29518376
Nightmare 1037.98 18.41 370 21629 11047 29541481
Anger 565.68 18.41 235 21764 10655 29541873
Irritability 458.54 18.41 254 21745 21898 29530630
Aggression 454.41 18.41 299 21700 35242 29517286
Insomnia 448.56 18.41 432 21567 88329 29464199
Agitation 428.53 18.41 333 21666 50971 29501557
Mood swings 415.71 18.41 168 21831 7083 29545445
Anxiety 383.84 18.41 390 21609 84975 29467553
Nausea 381.86 18.41 729 21270 288526 29264002
Feeling abnormal 350.88 18.41 304 21695 54141 29498387
Abnormal behaviour 253.38 18.41 177 21822 22950 29529578
Tobacco user 243.00 18.41 60 21939 461 29552067
Mood altered 215.63 18.41 110 21889 8001 29544527
Depressed mood 182.70 18.41 127 21872 16321 29536207
Paranoia 173.88 18.41 102 21897 9775 29542753
Personality change 162.59 18.41 76 21923 4562 29547966
Vomiting 157.37 18.41 427 21572 211833 29340695
Homicidal ideation 156.79 18.41 62 21937 2462 29550066
Off label use 132.33 18.41 31 21968 300769 29251759
Thinking abnormal 130.46 18.41 68 21931 5168 29547360
Hallucination 123.39 18.41 159 21840 44553 29507975
Nervousness 120.17 18.41 85 21914 11221 29541307
Amnesia 115.35 18.41 111 21888 22532 29529996
Acute kidney injury 115.30 18.41 28 21971 265239 29287289
Violence-related symptom 114.97 18.41 33 21966 474 29552054
Suicide attempt 112.97 18.41 133 21866 33977 29518551
Death 102.95 18.41 64 21935 342020 29210508
Drug hypersensitivity 101.23 18.41 182 21817 68224 29484304
Pneumonia 100.41 18.41 57 21942 320115 29232413
Emotional disorder 94.95 18.41 54 21945 4877 29547651
Pyrexia 94.84 18.41 48 21951 287574 29264954
Hostility 87.60 18.41 30 21969 787 29551741
Suicidal behaviour 86.42 18.41 34 21965 1331 29551197
Mania 82.62 18.41 61 21938 8602 29543926
Psychotic disorder 82.14 18.41 88 21911 20266 29532262
Toxicity to various agents 80.05 18.41 16 21983 173645 29378883
Sleep disorder 77.28 18.41 93 21906 24293 29528235
Panic attack 73.56 18.41 56 21943 8270 29544258
Crying 73.06 18.41 47 21952 5304 29547224
Sepsis 70.41 18.41 11 21988 142671 29409857
Alcohol use 67.67 18.41 37 21962 3095 29549433
Anaemia 66.94 18.41 33 21966 200918 29351610
Disturbance in attention 66.73 18.41 81 21918 21343 29531185
Neutropenia 65.33 18.41 10 21989 131701 29420827
Mental disorder 65.20 18.41 63 21936 12842 29539686
Thrombocytopenia 65.16 18.41 11 21988 134812 29417716
Physical assault 65.13 18.41 26 21973 1058 29551470
Febrile neutropenia 64.55 18.41 5 21994 112235 29440293
Apathy 57.83 18.41 43 21956 6128 29546400
Memory impairment 57.71 18.41 100 21899 36370 29516158
Impaired driving ability 54.44 18.41 29 21970 2302 29550226
Hypotension 53.43 18.41 40 21959 194314 29358214
Flatulence 51.99 18.41 65 21934 17644 29534884
Stress 50.92 18.41 71 21928 21419 29531109
Product use in unapproved indication 49.58 18.41 4 21995 86871 29465657
Impaired work ability 47.77 18.41 37 21962 5603 29546925
Bipolar disorder 47.61 18.41 30 21969 3265 29549263
Platelet count decreased 47.44 18.41 10 21989 104662 29447866
White blood cell count decreased 47.12 18.41 4 21995 83358 29469170
Self-injurious ideation 46.99 18.41 23 21976 1528 29551000
Pancytopenia 46.99 18.41 4 21995 83164 29469364
Affective disorder 46.52 18.41 29 21970 3097 29549431
Verbal abuse 46.48 18.41 13 21986 169 29552359
General physical health deterioration 46.26 18.41 10 21989 102847 29449681
Screaming 45.08 18.41 21 21978 1249 29551279
Somnambulism 44.29 18.41 27 21972 2771 29549757
Renal failure 41.72 18.41 18 21981 118581 29433947
Headache 41.07 18.41 245 21754 173762 29378766
Negative thoughts 41.04 18.41 16 21983 611 29551917
Haemoglobin decreased 40.49 18.41 15 21984 108360 29444168
Post-traumatic stress disorder 40.21 18.41 21 21978 1601 29550927
Dizziness 39.73 18.41 259 21740 189425 29363103
Urinary tract infection 36.99 18.41 5 21994 72349 29480179
Abdominal discomfort 36.87 18.41 98 21901 47805 29504723
Multiple organ dysfunction syndrome 35.74 18.41 3 21996 63113 29489415
Dysgeusia 35.63 18.41 62 21937 22612 29529916
Loss of personal independence in daily activities 35.42 18.41 66 21933 25374 29527154
Morbid thoughts 34.97 18.41 11 21988 219 29552309
Blood creatinine increased 34.91 18.41 10 21989 85092 29467436
Disease progression 34.78 18.41 9 21990 81907 29470621
Road traffic accident 34.77 18.41 50 21949 15511 29537017
Intentional self-injury 33.83 18.41 44 21955 12417 29540111
Social avoidant behaviour 33.30 18.41 23 21976 2919 29549609
Respiratory failure 32.20 18.41 16 21983 97115 29455413
Major depression 32.13 18.41 25 21974 3810 29548718
Dissociation 32 18.41 16 21983 1113 29551415
Palpitations 31.75 18.41 73 21926 32531 29519997
Tearfulness 31.72 18.41 18 21981 1618 29550910
Frustration tolerance decreased 31.28 18.41 20 21979 2232 29550296
Tobacco withdrawal symptoms 31.02 18.41 5 21994 0 29552528
Septic shock 30.42 18.41 5 21994 62555 29489973
Leukopenia 30.25 18.41 3 21996 55200 29497328
Withdrawal syndrome 28.58 18.41 38 21961 10954 29541574
Libido decreased 27.59 18.41 24 21975 4274 29548254
Anti-cyclic citrullinated peptide antibody positive 27.32 18.41 13 21986 811 29551717
Interstitial lung disease 27.22 18.41 5 21994 57713 29494815
Panic reaction 26.94 18.41 15 21984 1300 29551228
Feeling jittery 26.84 18.41 22 21977 3611 29548917
Drug screen false positive 26.51 18.41 12 21987 668 29551860
Disorientation 26.47 18.41 64 21935 29451 29523077
Cardiac failure 26.37 18.41 13 21986 79274 29473254
Renal impairment 26.06 18.41 14 21985 81319 29471209
Pleural effusion 25.13 18.41 11 21988 71897 29480631
Psychiatric symptom 25.05 18.41 20 21979 3164 29549364
Diarrhoea 24.67 18.41 146 21853 332552 29219976
Bradycardia 24.64 18.41 9 21990 65620 29486908
Mental impairment 24.38 18.41 32 21967 9109 29543419
Gun shot wound 23.94 18.41 13 21986 1072 29551456
Completed suicide 23.81 18.41 131 21868 90115 29462413
Loss of employment 23.54 18.41 10 21989 477 29552051
Infection 23.46 18.41 14 21985 76737 29475791
Fear 23.40 18.41 32 21967 9472 29543056
Hallucination, auditory 23.17 18.41 32 21967 9561 29542967
Drug withdrawal syndrome 22.99 18.41 45 21954 17939 29534589
Erectile dysfunction 22.95 18.41 45 21954 17964 29534564
Marital problem 22.62 18.41 6 21993 63 29552465
Sleep terror 22.48 18.41 11 21988 730 29551798
Asthma-chronic obstructive pulmonary disease overlap syndrome 22.46 18.41 11 21988 732 29551796
Hypokalaemia 22.31 18.41 5 21994 50198 29502330
Hypomania 22.29 18.41 16 21983 2159 29550369
Hyperkalaemia 22.08 18.41 9 21990 61383 29491145
Pharyngeal oedema 21.74 18.41 24 21975 5710 29546818
Hospitalisation 21.64 18.41 4 21995 45984 29506544
Depression suicidal 21.61 18.41 13 21986 1302 29551226
Feeding disorder 21.28 18.41 24 21975 5843 29546685
Tinnitus 21.10 18.41 40 21959 15574 29536954
Personality disorder 20.82 18.41 12 21987 1111 29551417
Confusional state 20.56 18.41 164 21835 127713 29424815
Decreased interest 20.26 18.41 15 21984 2123 29550405
Imprisonment 20.23 18.41 9 21990 481 29552047
Dehydration 20.12 18.41 34 21965 114714 29437814
Drug abuse 19.96 18.41 18 21981 79865 29472663
Affect lability 19.85 18.41 18 21981 3384 29549144
Restlessness 19.83 18.41 48 21951 22097 29530431
Atrial fibrillation 19.75 18.41 30 21969 105616 29446912
Flight of ideas 19.66 18.41 8 21991 342 29552186
Cellulitis 19.52 18.41 5 21994 45835 29506693
Alcohol interaction 19.20 18.41 16 21983 2687 29549841
Loss of consciousness 19.19 18.41 107 21892 73949 29478579
Oxygen saturation decreased 18.95 18.41 5 21994 44932 29507596
Cardio-respiratory arrest 18.89 18.41 7 21992 50594 29501934
Poor quality sleep 18.79 18.41 25 21974 7208 29545320
Seizure 18.73 18.41 126 21873 92997 29459531
Adjustment disorder with mixed anxiety and depressed mood 18.61 18.41 3 21996 0 29552528
Ill-defined disorder 18.43 18.41 32 21967 11646 29540882

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Abnormal dreams 1847.60 15.64 504 29569 9852 64458807
Depression 1492.38 15.64 973 29100 182318 64286341
Suicidal ideation 1473.00 15.64 685 29388 65857 64402802
Nightmare 1148.82 15.64 414 29659 20579 64448080
Anger 577.39 15.64 232 29841 15509 64453150
Nausea 484.84 15.64 1100 28973 784700 63683959
Anxiety 454.03 15.64 514 29559 202135 64266524
Irritability 443.53 15.64 252 29821 36494 64432165
Drug hypersensitivity 441.68 15.64 548 29525 237267 64231392
Aggression 430.02 15.64 268 29805 45964 64422695
Agitation 428.76 15.64 344 29729 88023 64380636
Insomnia 376.88 15.64 462 29611 197374 64271285
Mood swings 364.28 15.64 173 29900 17295 64451364
Feeling abnormal 342.39 15.64 364 29709 133238 64335421
Depressed mood 339.66 15.64 221 29852 40791 64427868
Abnormal behaviour 320.38 15.64 198 29875 33424 64435235
Mood altered 269.64 15.64 137 29936 15842 64452817
Crying 256.43 15.64 143 29930 19947 64448712
Paranoia 229.68 15.64 124 29949 16228 64452431
Tobacco user 210.06 15.64 51 30022 608 64468051
Tearfulness 161.36 15.64 66 30007 4607 64464052
Suicide attempt 159.94 15.64 181 29892 70826 64397833
Thinking abnormal 157.73 15.64 86 29987 11470 64457189
Vomiting 150.90 15.64 580 29493 550537 63918122
Psychotic disorder 139.19 15.64 121 29952 34457 64434202
Personality change 128.62 15.64 68 30005 8525 64460134
Homicidal ideation 126.27 15.64 50 30023 3207 64465452
Mania 123.19 15.64 83 29990 16203 64452456
Panic attack 117.51 15.64 89 29984 20864 64447795
Mental disorder 111.42 15.64 95 29978 26350 64442309
Off label use 105.01 15.64 85 29988 632721 63835938
Acute kidney injury 103.72 15.64 40 30033 449200 64019459
Emotional disorder 101.98 15.64 67 30006 12540 64456119
Amnesia 101.84 15.64 119 29954 48150 64420509
Anaemia 99.23 15.64 27 30046 378653 64090006
Suicidal behaviour 86.98 15.64 37 30036 2850 64465809
Pyrexia 86.58 15.64 80 29993 558564 63910095
Hallucination 85.51 15.64 135 29938 72653 64396006
Self-injurious ideation 80.15 15.64 36 30037 3161 64465498
Violence-related symptom 79.65 15.64 24 30049 671 64467988
Impaired work ability 75.23 15.64 60 30013 15159 64453500
Alcohol use 73.38 15.64 38 30035 4564 64464095
Neutropenia 70.93 15.64 13 30060 239611 64229048
Disturbance in attention 70.06 15.64 91 29982 40983 64427676
Toxicity to various agents 69.17 15.64 42 30031 363471 64105188
Hostility 68.86 15.64 29 30044 2178 64466481
Febrile neutropenia 68.30 15.64 5 30068 187652 64281007
Apathy 68.08 15.64 50 30023 11182 64457477
Sleep disorder 67.72 15.64 109 29964 59600 64409059
Nervousness 67.61 15.64 76 29997 29480 64439179
Thrombocytopenia 62.36 15.64 14 30059 223787 64244872
Negative thoughts 60.94 15.64 23 30050 1295 64467364
Bipolar disorder 57.29 15.64 37 30036 6724 64461935
Death 56.65 15.64 86 29987 482619 63986040
Pancytopenia 54.58 15.64 3 30070 143306 64325353
Stress 53.55 15.64 99 29974 60435 64408224
Affective disorder 53.29 15.64 35 30038 6545 64462114
Hypotension 51.66 15.64 61 30012 380913 64087746
Social avoidant behaviour 51.56 15.64 30 30043 4527 64464132
General physical health deterioration 50.87 15.64 16 30057 204409 64264250
Physical assault 50.54 15.64 21 30052 1525 64467134
Chronic obstructive pulmonary disease 50.50 15.64 106 29967 70942 64397717
Depression suicidal 50.00 15.64 24 30049 2451 64466208
Infusion related reaction 48.48 15.64 9 30064 164458 64304201
Blood creatinine increased 48.32 15.64 4 30069 135778 64332881
Somnambulism 48.22 15.64 30 30043 5111 64463548
Memory impairment 47.70 15.64 116 29957 85566 64383093
Sepsis 46.07 15.64 25 30048 230316 64238343
Delusion 45.85 15.64 49 30024 17965 64450694
Affect lability 45.62 15.64 36 30037 8954 64459705
Pre-existing condition improved 45.20 15.64 28 30045 4734 64463925
Withdrawal syndrome 44.74 15.64 55 30018 23437 64445222
Panic reaction 44.22 15.64 26 30047 4001 64464658
Major depression 43.37 15.64 33 30040 7783 64460876
Verbal abuse 43.08 15.64 12 30061 252 64468407
Flatulence 43.04 15.64 67 30006 35599 64433060
Urinary tract infection 42.30 15.64 28 30045 231568 64237091
Dizziness 40.88 15.64 341 29732 429822 64038837
Haemoglobin decreased 40.74 15.64 20 30053 195043 64273616
Screaming 39.32 15.64 23 30050 3506 64465153
Recalled product administered 37.90 15.64 14 30059 742 64467917
Alcohol interaction 37.08 15.64 24 30049 4377 64464282
Intentional self-injury 37.07 15.64 56 30017 28988 64439671
Road traffic accident 36.05 15.64 57 30016 30688 64437971
Platelet count decreased 35.32 15.64 17 30056 167694 64300965
Treatment failure 35.27 15.64 6 30067 116810 64351849
Fear 34.87 15.64 45 30028 20126 64448533
White blood cell count decreased 34.79 15.64 15 30058 157822 64310837
Dissociation 34.54 15.64 20 30053 2991 64465668
Therapeutic response unexpected 34.32 15.64 41 30032 16960 64451699
Palpitations 34.30 15.64 117 29956 104371 64364288
Infection 34.23 15.64 22 30051 184858 64283801
Loss of employment 34.06 15.64 17 30056 1890 64466769
Dysgeusia 33.20 15.64 70 30003 46977 64421682
Hallucination, auditory 32.81 15.64 40 30033 16899 64451760
Pneumonia 32.76 15.64 142 29931 559434 63909225
Product use in unapproved indication 32.72 15.64 21 30052 176597 64292062
Impaired driving ability 31.14 15.64 22 30051 4632 64464027
Leukopenia 31.01 15.64 5 30068 101237 64367422
Joint swelling 30.77 15.64 33 30040 215349 64253310
Post-traumatic stress disorder 30.76 15.64 21 30052 4184 64464475
Decreased interest 29.99 15.64 19 30054 3341 64465318
Hypokalaemia 29.50 15.64 10 30063 121893 64346766
Hypomania 29.47 15.64 23 30050 5631 64463028
Renal failure 29.26 15.64 25 30048 181663 64286996
Multiple organ dysfunction syndrome 28.93 15.64 6 30067 101407 64367252
Impulsive behaviour 28.73 15.64 17 30056 2646 64466013
Tachyphrenia 28.51 15.64 15 30058 1861 64466798
Seizure 27.68 15.64 152 29921 166740 64301919
Cardiac failure 26.99 15.64 14 30059 132359 64336300
Feeling of despair 26.68 15.64 16 30057 2552 64466107
Pleural effusion 26.38 15.64 13 30060 126546 64342113
Asthma-chronic obstructive pulmonary disease overlap syndrome 26.09 15.64 12 30061 1113 64467546
Disease progression 26.03 15.64 17 30056 141663 64326996
Flat affect 25.83 15.64 14 30059 1843 64466816
Frustration tolerance decreased 25.78 15.64 22 30051 6103 64462556
Cardio-respiratory arrest 25.74 15.64 7 30066 98386 64370273
Tobacco withdrawal symptoms 24.45 15.64 4 30069 3 64468656
Flight of ideas 24.40 15.64 10 30063 701 64467958
Contraindicated product administered 24.15 15.64 10 30063 107819 64360840
Agoraphobia 23.33 15.64 9 30064 538 64468121
Psychiatric symptom 23.33 15.64 21 30052 6252 64462407
Hepatic enzyme increased 23.32 15.64 16 30057 129927 64338732
Headache 23.28 15.64 361 29712 529106 63939553
Hyperkalaemia 23.27 15.64 9 30064 101120 64367539
Arthropathy 22.92 15.64 14 30059 120953 64347706
Marital problem 22.63 15.64 7 30066 214 64468445
Arthralgia 22.47 15.64 118 29955 442142 64026517
Renal impairment 22.45 15.64 18 30055 134999 64333660
Disorientation 22.40 15.64 67 30006 55761 64412898
Weaning failure 22.15 15.64 9 30064 617 64468042
Interstitial lung disease 21.99 15.64 9 30064 97723 64370936
Alopecia 21.91 15.64 27 30046 165663 64302996
Bronchial hyperreactivity 21.91 15.64 14 30059 2498 64466161
Flashback 21.33 15.64 7 30066 260 64468399
Obsessive thoughts 20.96 15.64 10 30063 1007 64467652
Morbid thoughts 20.86 15.64 9 30064 717 64467942
Agitated depression 20.55 15.64 7 30066 292 64468367
Hospitalisation 20.34 15.64 5 30068 75202 64393457
Drug withdrawal syndrome 20.29 15.64 45 30028 31246 64437413
Septic shock 20.26 15.64 12 30061 105425 64363234
Pharyngeal oedema 19.89 15.64 30 30043 15501 64453158
Hypersomnia 19.67 15.64 34 30039 19683 64448976
Respiratory failure 19.55 15.64 28 30045 161155 64307504
Systemic lupus erythematosus 19.42 15.64 6 30067 77606 64391053
Alcohol poisoning 19.39 15.64 16 30057 4239 64464420
Malaise 19.27 15.64 275 29798 395972 64072687
Drug abuse 19.21 15.64 20 30053 132354 64336305
Formication 19.06 15.64 16 30057 4341 64464318
Euphoric mood 18.69 15.64 19 30054 6572 64462087
Rheumatoid arthritis 18.52 15.64 30 30043 164264 64304395
Nasopharyngitis 18.40 15.64 40 30033 196033 64272626
Energy increased 18.36 15.64 13 30060 2745 64465914
Bipolar I disorder 18.31 15.64 11 30062 1760 64466899
Dehydration 18.13 15.64 47 30026 216716 64251943
Sinusitis 18.04 15.64 25 30048 145903 64322756
Pneumonia aspiration 17.98 15.64 3 30070 59268 64409391
C-reactive protein increased 17.96 15.64 11 30062 94898 64373761
Schizophrenia 17.89 15.64 24 30049 11144 64457515
Libido decreased 17.76 15.64 16 30057 4768 64463891
Exposure during pregnancy 17.73 15.64 7 30066 77668 64390991
Atrial fibrillation 17.68 15.64 33 30040 171056 64297603
Cellulitis 17.52 15.64 11 30062 93646 64375013
Aspartate aminotransferase increased 17.49 15.64 18 30055 119770 64348889
Blood bilirubin increased 17.27 15.64 3 30070 57550 64411109
Feelings of worthlessness 17.24 15.64 7 30066 479 64468180
Pericarditis 17.22 15.64 4 30069 62512 64406147
Loss of personal independence in daily activities 17.06 15.64 73 30000 72381 64396278
Large intestine polyp 16.92 15.64 23 30050 10814 64457845
Pulmonary function test abnormal 16.77 15.64 13 30060 3151 64465508
Nicotine dependence 16.77 15.64 8 30065 806 64467853
Therapy non-responder 16.66 15.64 5 30068 65894 64402765
Depressive symptom 16.62 15.64 15 30058 4481 64464178
Sleep terror 16.58 15.64 9 30064 1188 64467471
Loss of consciousness 16.44 15.64 122 29951 148243 64320416
Impaired healing 16.39 15.64 4 30069 60469 64408190
Hepatic failure 16.38 15.64 3 30070 55391 64413268
Restlessness 16.20 15.64 48 30025 39737 64428922
Glossodynia 16.19 15.64 5 30068 64691 64403968
Economic problem 16.18 15.64 11 30062 2176 64466483
Panic disorder 16.09 15.64 12 30061 2745 64465914
Bradycardia 15.91 15.64 19 30054 118200 64350459
Drug reaction with eosinophilia and systemic symptoms 15.89 15.64 3 30070 54214 64414445
Plantar fasciitis 15.85 15.64 12 30061 2808 64465851
Oxygen saturation decreased 15.77 15.64 16 30057 107160 64361499
Neuropathy peripheral 15.69 15.64 19 30054 117506 64351153
Oedema mouth 15.65 15.64 12 30061 2861 64465798

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC N07BA03 NERVOUS SYSTEM
OTHER NERVOUS SYSTEM DRUGS
DRUGS USED IN ADDICTIVE DISORDERS
Drugs used in nicotine dependence
FDA MoA N0000175369 Cholinergic Agonists
MeSH PA D018678 Cholinergic Agents
MeSH PA D018679 Cholinergic Agonists
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D018722 Nicotinic Agonists
MeSH PA D000077444 Smoking Cessation Agents
FDA MoA N0000175702 Partial Cholinergic Nicotinic Agonists
FDA EPC N0000175705 Partial Cholinergic Nicotinic Agonist
FDA EPC N0000175884 Cholinergic Receptor Agonist
CHEBI has role CHEBI:35941 serotonin agonists
CHEBI has role CHEBI:47958 muscarinic agonists

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Smoking cessation assistance indication 384742004
Suicidal thoughts contraindication 6471006
Alcoholism contraindication 7200002
Bipolar disorder contraindication 13746004 DOID:3312
Mood swings contraindication 18963009
Feeling agitated contraindication 24199005
Alcohol intoxication contraindication 25702006
Depressive disorder contraindication 35489007
Schizophrenia contraindication 58214004 DOID:5419
Acute nephropathy contraindication 58574008
Aggressive behavior contraindication 61372001
Aortocoronary artery bypass graft contraindication 67166004
Hostile behavior contraindication 79351003
Angina pectoris contraindication 194828000
Acute coronary syndrome contraindication 394659003
Cardiovascular event risk contraindication 395112001
Peripheral vascular disease contraindication 400047006
Nausea contraindication 422587007




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 8.83 Basic
pKa2 1.25 Basic

Orange Book patent data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRoutePatent numberPatent expiration datePatent use
EQ 0.5MG BASE CHANTIX PF PRISM CV N021928 May 10, 2006 DISCN TABLET ORAL 6890927 May 6, 2022 AID TO SMOKING CESSATION
EQ 1MG BASE CHANTIX PF PRISM CV N021928 May 10, 2006 DISCN TABLET ORAL 6890927 May 6, 2022 AID TO SMOKING CESSATION
EQ 0.5MG BASE CHANTIX PF PRISM CV N021928 May 10, 2006 DISCN TABLET ORAL 7265119 Aug. 3, 2022 AID TO SMOKING CESSATION
EQ 1MG BASE CHANTIX PF PRISM CV N021928 May 10, 2006 DISCN TABLET ORAL 7265119 Aug. 3, 2022 AID TO SMOKING CESSATION
EQ 0.03MG BASE/SPRAY TYRVAYA OYSTER POINT PHARMA N213978 Oct. 15, 2021 RX SOLUTION NASAL 10456396 Oct. 19, 2035 TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
EQ 0.03MG BASE/SPRAY TYRVAYA OYSTER POINT PHARMA N213978 Oct. 15, 2021 RX SOLUTION NASAL 11224598 Oct. 19, 2035 TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
EQ 0.03MG BASE/SPRAY TYRVAYA OYSTER POINT PHARMA N213978 Oct. 15, 2021 RX SOLUTION NASAL 9504644 Oct. 19, 2035 TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
EQ 0.03MG BASE/SPRAY TYRVAYA OYSTER POINT PHARMA N213978 Oct. 15, 2021 RX SOLUTION NASAL 9532944 Oct. 19, 2035 TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
EQ 0.03MG BASE/SPRAY TYRVAYA OYSTER POINT PHARMA N213978 Oct. 15, 2021 RX SOLUTION NASAL 9597284 Oct. 19, 2035 TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)

Orange Book exclusivity data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRouteExclusivity dateDescription
EQ 0.5MG BASE CHANTIX PF PRISM CV N021928 May 10, 2006 DISCN TABLET ORAL Feb. 22, 2022 INFORMATION ADDED TO LABELING TO DESCRIBE A STUDY TO EVALUATE THE SAFETY AND EFFICACY OF VARENICLINE FOR SMOKING CESSATION IN ADOLESCENT SMOKERS
EQ 1MG BASE CHANTIX PF PRISM CV N021928 May 10, 2006 DISCN TABLET ORAL Feb. 22, 2022 INFORMATION ADDED TO LABELING TO DESCRIBE A STUDY TO EVALUATE THE SAFETY AND EFFICACY OF VARENICLINE FOR SMOKING CESSATION IN ADOLESCENT SMOKERS
EQ 0.5MG BASE CHANTIX PF PRISM CV N021928 May 10, 2006 DISCN TABLET ORAL Aug. 22, 2022 PEDIATRIC EXCLUSIVITY
EQ 1MG BASE CHANTIX PF PRISM CV N021928 May 10, 2006 DISCN TABLET ORAL Aug. 22, 2022 PEDIATRIC EXCLUSIVITY
EQ 0.03MG BASE/SPRAY TYRVAYA OYSTER POINT PHARMA N213978 Oct. 15, 2021 RX SOLUTION NASAL Oct. 15, 2024 NEW PRODUCT

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Neuronal acetylcholine receptor; alpha4/beta2 Ion channel AGONIST Ki 9.40 WOMBAT-PK CHEMBL
Neuronal acetylcholine receptor; alpha3/beta4 Ion channel Ki 7.07 WOMBAT-PK
Neuronal acetylcholine receptor; alpha4/beta4 Ion channel Ki 6.96 CHEMBL
Acetylcholine receptor; alpha1/beta1/delta/gamma Ion channel Ki 5.09 CHEMBL
Neuronal acetylcholine receptor subunit alpha-7 Ion channel Ki 6.90 CHEMBL
Neuronal acetylcholine receptor subunit alpha-7 Ion channel Ki 7.49 CHEMBL
Neuronal acetylcholine receptor; alpha2/beta2 Ion channel Ki 9.66 CHEMBL
Neuronal acetylcholine receptor; alpha3/beta2 Ion channel Ki 8.72 CHEMBL
Neuronal acetylcholine receptor; alpha3/beta4 Ion channel Ki 7.07 CHEMBL
Neuronal acetylcholine receptor; alpha4/beta2 Ion channel Ki 10.30 CHEMBL
Neuronal acetylcholine receptor; alpha4/beta4 Ion channel Ki 7.82 CHEMBL
Neuronal acetylcholine receptor; alpha2/beta4 Ion channel Ki 7.15 CHEMBL
Acetylcholine receptor Ion channel Ki 5.45 CHEMBL

External reference:

IDSource
4025278 VUID
N0000179790 NUI
D06282 KEGG_DRUG
375815-87-5 SECONDARY_CAS_RN
4025278 VANDF
4025594 VANDF
C1569608 UMLSCUI
CHEBI:84500 CHEBI
QMR PDB_CHEM_ID
CHEMBL1396 ChEMBL_ID
DB01273 DRUGBANK_ID
CHEMBL2062259 ChEMBL_ID
D000068580 MESH_DESCRIPTOR_UI
170361 PUBCHEM_CID
8366 INN_ID
5459 IUPHAR_LIGAND_ID
W6HS99O8ZO UNII
591622 RXNORM
21404 MMSL
348368 MMSL
82173 MMSL
d05807 MMSL
011508 NDDF
011509 NDDF
420507002 SNOMEDCT_US
421772003 SNOMEDCT_US
428382005 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 0069-0468 TABLET, FILM COATED 0.50 mg ORAL NDA 30 sections
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 0069-0469 TABLET, FILM COATED 1 mg ORAL NDA 30 sections
Chantix HUMAN PRESCRIPTION DRUG LABEL 1 21695-633 TABLET, FILM COATED 0.50 mg ORAL NDA 31 sections
Chantix HUMAN PRESCRIPTION DRUG LABEL 1 21695-946 TABLET, FILM COATED 1 mg ORAL NDA 31 sections
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 43353-899 TABLET, FILM COATED 1 mg ORAL NDA 30 sections
Varenicline HUMAN PRESCRIPTION DRUG LABEL 1 49884-155 TABLET, FILM COATED 0.50 mg ORAL ANDA 27 sections
Varenicline HUMAN PRESCRIPTION DRUG LABEL 1 49884-156 TABLET, FILM COATED 1 mg ORAL ANDA 27 sections
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 50090-0995 TABLET, FILM COATED 1 mg ORAL NDA 29 sections
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 50090-0995 TABLET, FILM COATED 1 mg ORAL NDA 29 sections
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 50090-4481 TABLET, FILM COATED 0.50 mg ORAL NDA 30 sections
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 50090-4482 TABLET, FILM COATED 1 mg ORAL NDA 30 sections
Chantix HUMAN PRESCRIPTION DRUG LABEL 1 54868-5674 TABLET, FILM COATED 1 mg ORAL NDA 31 sections
APO-VARENICLINE HUMAN PRESCRIPTION DRUG LABEL 1 60505-4765 TABLET, FILM COATED 0.50 mg ORAL Unapproved drug for use in drug shortage 7 sections
APO-VARENICLINE HUMAN PRESCRIPTION DRUG LABEL 1 60505-4766 TABLET, FILM COATED 1 mg ORAL Unapproved drug for use in drug shortage 7 sections
Varenicline HUMAN PRESCRIPTION DRUG LABEL 1 60687-648 TABLET, FILM COATED 1 mg ORAL ANDA 27 sections
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 68151-4952 TABLET, FILM COATED 1 mg ORAL NDA 31 sections
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 68151-4953 TABLET, FILM COATED 0.50 mg ORAL NDA 31 sections
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 69189-0492 TABLET, FILM COATED 0.50 mg ORAL NDA 30 sections
CHANTIX HUMAN PRESCRIPTION DRUG LABEL 1 71205-381 TABLET, FILM COATED 1 mg ORAL NDA 30 sections
Tyrvaya HUMAN PRESCRIPTION DRUG LABEL 1 73521-030 SPRAY 0.03 mg NASAL NDA 24 sections